{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:45:23Z","timestamp":1792233923476,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015595","name":"GHR Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008908","name":"Foundation for Neurologic Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008908","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006691","name":"Harvard Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.tjpad.2026.100503","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:28:49Z","timestamp":1770366529000},"page":"100503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Digital memory assessments and plasma pTau217 enable efficient preclinical Alzheimer\u2019s trials"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8233-5829","authenticated-orcid":false,"given":"Casey R.","family":"Vanderlip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Gillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-8502","authenticated-orcid":false,"given":"Craig E.L.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.tjpad.2026.100503_bib0001","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","article-title":"Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline","volume":"28","author":"Ossenkoppele","year":"2022","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.tjpad.2026.100503_bib0002","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S1474-4422(22)00298-8","article-title":"Advances in Alzheimer\u2019s disease research over the past two decades","volume":"21","author":"Jack","year":"2022","journal-title":"Lancet Neurol"},{"issue":"228","key":"10.1016\/j.tjpad.2026.100503_bib0003","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100503_bib0004","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/alz.12748","article-title":"The AHEAD 3-45 study: design of a prevention trial for Alzheimer\u2019s disease","volume":"19","author":"Rafii","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"12","key":"10.1016\/j.tjpad.2026.100503_bib0005","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of Solanezumab in preclinical Alzheimer\u2019s disease","volume":"389","author":"Sperling","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.tjpad.2026.100503_bib0006","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/acn3.51048","article-title":"The A4 study: \u03b2-amyloid and cognition in 4432 cognitively unimpaired adults","volume":"7","author":"Insel","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.tjpad.2026.100503_bib0007","article-title":"Alzheimer disease as a clinical-biological construct\u2014An International Working Group recommendation","volume":"1","author":"Dubois","year":"2024","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1016\/j.tjpad.2026.100503_bib0008","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1002\/alz.14184","article-title":"Recommendations for clinical implementation of blood-based biomarkers for Alzheimer\u2019s disease","volume":"20","author":"Mielke","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100503_bib0009","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","article-title":"Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers","volume":"80","author":"Mattsson-Carlgren","year":"2023","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.tjpad.2026.100503_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70662","article-title":"Donanemab in preclinical Alzheimer\u2019s disease: screening and baseline data from TRAILBLAZER-ALZ 3","volume":"21","author":"Yaari","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100503_bib0011","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer Disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.tjpad.2026.100503_bib0012","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/brain\/awad042","article-title":"Predicting amyloid PET and tau PET stages with plasma biomarkers","volume":"146","author":"Jack","year":"2023","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.tjpad.2026.100503_bib0013","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jamaneurol.2025.2974","article-title":"Concurrent changes in plasma phosphorylated tau 217, tau PET, and cognition in preclinical Alzheimer disease","volume":"82","author":"Insel","year":"2025","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.tjpad.2026.100503_bib0014","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1002\/alz.13919","article-title":"Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer\u2019s disease","volume":"20","author":"Berron","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100503_bib0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41746-025-01583-5","article-title":"A scoping review of remote and unsupervised digital cognitive assessments in preclinical Alzheimer\u2019s disease","volume":"8","author":"Polk","year":"2025","journal-title":"Npj Digit Med."},{"key":"10.1016\/j.tjpad.2026.100503_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14154","article-title":"for the Alzheimer\u2019s Disease Neuroimaging Initiative. Digital cognitive assessments as low-burden markers for predicting future cognitive decline and tau accumulation across the Alzheimer\u2019s spectrum","author":"Vanderlip","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"10","key":"10.1016\/j.tjpad.2026.100503_bib0017","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrn3085","article-title":"A pathophysiological framework of hippocampal dysfunction in ageing and disease","volume":"12","author":"Small","year":"2011","journal-title":"Nat Rev Neurosci."},{"issue":"2","key":"10.1016\/j.tjpad.2026.100503_bib0018","article-title":"Differential involvement of hippocampal subfields in the relationship between Alzheimer\u2019s pathology and memory interference in older adults","volume":"15","author":"Adams","year":"2023","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100503_bib0019","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1037\/0033-295X.102.3.419","article-title":"Why there are complementary learning systems in the hippocampus and neocortex: insights from the successes and failures of connectionist models of learning and memory","volume":"102","author":"McClelland","year":"1995","journal-title":"Psychol Rev."},{"key":"10.1016\/j.tjpad.2026.100503_bib0020","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.neuropsychologia.2012.06.011","article-title":"Goodrich-Hunsaker NJ, Hopkins RO, Stark CE. Pattern separation deficits following damage to the hippocampus","volume":"50","author":"Kirwan","year":"2012","journal-title":"Neuropsychologia"},{"issue":"15-18","key":"10.1016\/j.tjpad.2026.100503_bib0021","article-title":"Distinct pattern separation related transfer functions in human CA3\/dentate and CA1 revealed using high-resolution fMRI and variable mnemonic similarity","volume":"18","author":"Lacy","year":"2011","journal-title":"Learn Mem"},{"key":"10.1016\/j.tjpad.2026.100503_bib0022","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1101\/lm.663507","article-title":"Overcoming interference: an fMRI investigation of pattern separation in the medial temporal lobe","volume":"14","author":"Kirwan","year":"2007","journal-title":"Learn Mem"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100503_bib0023","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/hipo.22223","article-title":"Contributions of human hippocampal subfields to spatial and temporal pattern separation","volume":"24","author":"Azab","year":"2014","journal-title":"Hippocampus"},{"key":"10.1016\/j.tjpad.2026.100503_bib0024","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.neuropsychologia.2012.12.014","article-title":"A task to assess behavioral pattern separation (BPS) in humans: data from healthy aging and mild cognitive impairment","volume":"51","author":"Stark","year":"2013","journal-title":"Neuropsychologia"},{"issue":"12","key":"10.1016\/j.tjpad.2026.100503_bib0025","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/hipo.22162","article-title":"Pattern separation and pattern completion in Alzheimer\u2019s disease: evidence of rapid forgetting in amnestic mild cognitive impairment","volume":"23","author":"Ally","year":"2013","journal-title":"Hippocampus."},{"key":"10.1016\/j.tjpad.2026.100503_bib0026","unstructured":"Vanderlip C, Stark CEL. Integrating plasma pTau-217 and digital cognitive assessments for early detection in Alzheimer\u2019s disease. Alzheimers Dement. Published online in press."},{"key":"10.1016\/j.tjpad.2026.100503_bib0027","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1605-24.2025","article-title":"Amyloid-\u03b2 deposition in basal frontotemporal cortex is associated with selective disruption of temporal mnemonic discrimination","author":"Vanderlip","year":"2025","journal-title":"J Neurosci"},{"key":"10.1016\/j.tjpad.2026.100503_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14163","article-title":"Cognitive modeling of the Mnemonic Similarity Task as a digital biomarker for Alzheimer\u2019s disease","author":"Vanderlip","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100503_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.800126","article-title":"Monthly At-home computerized cognitive testing to detect diminished practice effects in preclinical Alzheimer\u2019s disease","volume":"13","author":"Jutten","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.tjpad.2026.100503_bib0030","first-page":"1","article-title":"The Computerized Cognitive Composite (C3) in A4, an Alzheimer\u2019s Disease secondary prevention trial","author":"Papp","year":"2020","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100503_bib0031","doi-asserted-by":"crossref","first-page":"889","DOI":"10.14283\/jpad.2024.120","article-title":"Maximizing the utility of Alzheimer\u2019s Disease trial data: sharing of baseline A4 and LEARN data","volume":"11","author":"Jimenez-Maggiora","year":"2024","journal-title":"J Prev Alzheimers Dis."},{"issue":"11","key":"10.1016\/j.tjpad.2026.100503_bib0032","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.tics.2019.08.003","article-title":"Mnemonic similarity task: A tool for assessing hippocampal integrity","volume":"23","author":"Stark","year":"2019","journal-title":"Trends Cogn Sci."},{"key":"10.1016\/j.tjpad.2026.100503_bib0033","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbr.2017.06.049","article-title":"Age-related deficits in the mnemonic similarity task for objects and scenes","volume":"333","author":"Stark","year":"2017","journal-title":"Behav Brain Res."},{"issue":"9","key":"10.1016\/j.tjpad.2026.100503_bib0034","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1016\/j.neuropsychologia.2011.06.006","article-title":"Face-name associative memory performance is related to amyloid burden in normal elderly","volume":"49","author":"Rentz","year":"2011","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.tjpad.2026.100503_bib0035","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/13803395.2012.666230","article-title":"Validation of the face name associative memory exam in cognitively normal older individuals","volume":"34","author":"Amariglio","year":"2012","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1016\/j.tjpad.2026.100503_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2021.780303","article-title":"A paradox in digital memory assessment: increased sensitivity with reduced difficulty","volume":"3","author":"White","year":"2021","journal-title":"Front Digit Health"},{"issue":"8","key":"10.1016\/j.tjpad.2026.100503_bib0037","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","article-title":"The preclinical Alzheimer cognitive composite: measuring amyloid-related decline","volume":"71","author":"Donohue","year":"2014","journal-title":"JAMA Neurol"},{"issue":"22","key":"10.1016\/j.tjpad.2026.100503_bib0038","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.2017.6669","article-title":"Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons","volume":"317","author":"Donohue","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100503_bib0039","doi-asserted-by":"crossref","first-page":"823","DOI":"10.14283\/jpad.2024.134","article-title":"Longitudinal phospho-tau217 predicts amyloid positron emission tomography in asymptomatic Alzheimer\u2019s disease","volume":"11","author":"Rissman","year":"2024","journal-title":"J Prev Alzheimers Dis."},{"issue":"403","key":"10.1016\/j.tjpad.2026.100503_bib0040","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/01621459.1988.10478639","article-title":"Locally weighted regression: an approach to regression analysis by local fitting","volume":"83","author":"Cleveland","year":"1988","journal-title":"J Am Stat Assoc."},{"issue":"2","key":"10.1016\/j.tjpad.2026.100503_bib0041","doi-asserted-by":"crossref","DOI":"10.1214\/ss\/1009213286","article-title":"Interval estimation for a binomial proportion","volume":"16","author":"Brown","year":"2001","journal-title":"Stat Sci"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100503_bib0042","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/alz.13542","article-title":"Plasma A\u03b242\/A\u03b240 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer\u2019s disease","volume":"20","author":"Rissman","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.tjpad.2026.100503_bib0043","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41582-022-00645-6","article-title":"Early-stage Alzheimer disease: getting trial-ready","volume":"18","author":"Aisen","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100503_bib0044","doi-asserted-by":"crossref","first-page":"208","DOI":"10.14283\/jpad.2020.45","article-title":"The trial-ready cohort for preclinical\/prodromal Alzheimer\u2019s Disease (TRC-PAD) project: an overview","volume":"7","author":"Aisen","year":"2020","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100503_bib0045","doi-asserted-by":"crossref","first-page":"234","DOI":"10.14283\/jpad.2020.47","article-title":"The trial-ready cohort for preclinical and prodromal Alzheimer\u2019s disease (TRC-PAD): experience from the first 3 years","volume":"7","author":"Walter","year":"2020","journal-title":"J Prev Alzheimers Dis."},{"issue":"S14","key":"10.1016\/j.tjpad.2026.100503_bib0046","doi-asserted-by":"crossref","DOI":"10.1002\/alz.080275","article-title":"A finger prick collection method for detecting blood biomarkers of neurodegeneration \u2013 a pilot study (DROP-AD)","volume":"19","author":"Huber","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.tjpad.2026.100503_bib0047","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100503_bib0048","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s Disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N Engl J Med"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:53:20Z","timestamp":1776927200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580726000270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2274580726000270"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100503","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Digital memory assessments and plasma pTau217 enable efficient preclinical Alzheimer\u2019s trials","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100503"}}